284 related articles for article (PubMed ID: 31340863)
1. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target.
Thomas P; Pranatharthi A; Ross C; Srivastava S
J Exp Clin Cancer Res; 2019 Jul; 38(1):328. PubMed ID: 31340863
[TBL] [Abstract][Full Text] [Related]
2. RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes.
Thomas P; Srivastava S; Udayashankara AH; Damodaran S; Yadav L; Mathew B; Suresh SB; Mandal AK; Srikantia N
Cell Mol Life Sci; 2022 Dec; 80(1):1. PubMed ID: 36469134
[TBL] [Abstract][Full Text] [Related]
3. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
Pranatharthi A; Thomas P; Udayashankar AH; Bhavani C; Suresh SB; Krishna S; Thatte J; Srikantia N; Ross CR; Srivastava S
J Exp Clin Cancer Res; 2019 Sep; 38(1):392. PubMed ID: 31488179
[TBL] [Abstract][Full Text] [Related]
4. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
[TBL] [Abstract][Full Text] [Related]
5. RhoC impacts the metastatic potential and abundance of breast cancer stem cells.
Rosenthal DT; Zhang J; Bao L; Zhu L; Wu Z; Toy K; Kleer CG; Merajver SD
PLoS One; 2012; 7(7):e40979. PubMed ID: 22911725
[TBL] [Abstract][Full Text] [Related]
6. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
[TBL] [Abstract][Full Text] [Related]
7. HIF-3α Promotes Metastatic Phenotypes in Pancreatic Cancer by Transcriptional Regulation of the RhoC-ROCK1 Signaling Pathway.
Zhou X; Guo X; Chen M; Xie C; Jiang J
Mol Cancer Res; 2018 Jan; 16(1):124-134. PubMed ID: 28928287
[TBL] [Abstract][Full Text] [Related]
8. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
9. p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.
Rosenthal DT; Iyer H; Escudero S; Bao L; Wu Z; Ventura AC; Kleer CG; Arruda EM; Garikipati K; Merajver SD
Cancer Res; 2011 Oct; 71(20):6338-49. PubMed ID: 21862636
[TBL] [Abstract][Full Text] [Related]
10. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
11. The role of RhoC in malignant tumor invasion, metastasis and targeted therapy.
Guan X; Chen S; Zhao Y
Histol Histopathol; 2018 Mar; 33(3):255-260. PubMed ID: 28664531
[TBL] [Abstract][Full Text] [Related]
12. Effects of RhoC downregulation on the angiogenesis characteristics of myeloma vascular endothelial cells.
Zhao Z; Liu K; Tian X; Sun M; Wei N; Zhu X; Yang H; Wang T; Jiang G; Chen K
Cancer Med; 2019 Jul; 8(7):3502-3510. PubMed ID: 31062507
[TBL] [Abstract][Full Text] [Related]
13. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.
Kaushal N; Tiruchinapally G; Durmaz YY; Bao L; Gilani R; Merajver SD; ElSayed MEH
J Control Release; 2018 Nov; 289():79-93. PubMed ID: 30149048
[TBL] [Abstract][Full Text] [Related]
15. RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.
Yao H; Dashner EJ; van Golen CM; van Golen KL
Oncogene; 2006 Apr; 25(16):2285-96. PubMed ID: 16314838
[TBL] [Abstract][Full Text] [Related]
16. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.
Ikoma T; Takahashi T; Nagano S; Li YM; Ohno Y; Ando K; Fujiwara T; Fujiwara H; Kosai K
Clin Cancer Res; 2004 Feb; 10(3):1192-200. PubMed ID: 14871999
[TBL] [Abstract][Full Text] [Related]
17. A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC.
Xu M; Huang S; Dong X; Chen Y; Li M; Shi W; Wang G; Huang C; Wang Q; Liu Y; Sun P; Yang S; Xiang R; Chang A
J Mol Cell Biol; 2021 Apr; 13(1):59-71. PubMed ID: 33049034
[TBL] [Abstract][Full Text] [Related]
18. RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells.
Wu Z; Liu H; Sun W; Du Y; He W; Guo S; Chen L; Zhao Z; Wang P; Liang H; Deng J
Cell Death Dis; 2020 Oct; 11(10):881. PubMed ID: 33082325
[TBL] [Abstract][Full Text] [Related]
19. RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination.
Rong G; Pan Z; Ding M; Wang L
Environ Toxicol; 2022 Mar; 37(3):603-611. PubMed ID: 34873829
[TBL] [Abstract][Full Text] [Related]
20. Formin-like 3 regulates RhoC/FAK pathway and actin assembly to promote cell invasion in colorectal carcinoma.
Zeng YF; Xiao YS; Liu Y; Luo XJ; Wen LD; Liu Q; Chen M
World J Gastroenterol; 2018 Sep; 24(34):3884-3897. PubMed ID: 30228782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
